Skip to content

Comparison of normal saline with normal saline plus antibiotic in abdominal lavage in secondary peritonitis

Clinical trials of normal saline with normal saline plus antibiotic in abdominal lavage in secondary peritonitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016092529818N1
Enrollment
80
Registered
2016-10-30
Start date
2016-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritonitis. Acute peritonitis

Interventions

Intervention 1: Intervention 1: normal saline and antibiotics gentamicin, gentamicin 240 mg per 500 mL of saline once during surgery. Normal saline containing 9.0 g of salt per liter (0.90%) and genta
Treatment - Drugs
Intervention 1: normal saline and antibiotics gentamicin, gentamicin 240 mg per 500 mL of saline once during surgery. Normal saline containing 9.0 g of salt per liter (0.90%) and gentamicin formula is
Intervention 2: normal saline, per 500 mL of saline once during surgery. Normal saline containing 9.0 g of salt per liter (0.90%). How to use: At the end of surgery, a stomach lavage with antibiotic g

Sponsors

Vice chancellor for research, Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with the diagnosis of secondary peritonitis that have age between 15 to 60 years will undergo for urgent laparotomy were included. Exclusion criteria: A history of allergy to gentamicin, normal saline; history of kidney disease, dialysis, hemodialysis, uncontrolled hypertension; evidence of infection at or adjacent to the operative site; and the perceived inability to follow the patient’s course postoperative; patients with peritoneal carcinomatosis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Infection. Timepoint: One and two weeks after operation. Method of measurement: Medical evaluation.

Secondary

MeasureTime frame
Recurrence. Timepoint: One and two weeks after operation. Method of measurement: Medical evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahram Manoochehry

Baqiyatallah University of Medical Sciences

shahram.manoochehry@yahoo.com+98 21 8805 3766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026